Global Gastro Esophageal Reflux Disease Drug and Devices Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Gastro Esophageal Reflux Disease Drug and Devices Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size Growth Rate by Product
  • 1.4.2 Medigus Ultrasonic Surgical Endostapler
  • 1.4.3 LINX Management System
  • 1.4.4 Stretta Therapy
  • 1.4.5 Bravo Reflux Testing System
  • 1.4.6 Digitrapper Reflux Testing System
  • 1.4.7 Others
• 1.5 Market by End User
  • 1.5.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size Growth Rate by End User
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size
  • 2.1.1 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue 2014-2025
  • 2.1.2 Global Gastro Esophageal Reflux Disease Drug and Devices Sales 2014-2025
• 2.2 Gastro Esophageal Reflux Disease Drug and Devices Growth Rate by Regions
  • 2.2.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales by Regions
  • 2.2.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Gastro Esophageal Reflux Disease Drug and Devices Sales by Manufacturers
  • 3.1.1 Gastro Esophageal Reflux Disease Drug and Devices Sales by Manufacturers
  • 3.1.2 Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Manufacturers
  • 3.1.3 Global Gastro Esophageal Reflux Disease Drug and Devices Market Concentration Ratio (CR5 and HHI)
• 3.2 Gastro Esophageal Reflux Disease Drug and Devices Revenue by Manufacturers
  • 3.2.1 Gastro Esophageal Reflux Disease Drug and Devices Revenue by Manufacturers (2014-2019)
  • 3.2.2 Gastro Esophageal Reflux Disease Drug and Devices Revenue Share by Manufacturers (2014-2019)
• 3.3 Gastro Esophageal Reflux Disease Drug and Devices Price by Manufacturers
• 3.4 Gastro Esophageal Reflux Disease Drug and Devices Manufacturing Base Distribution, Product Types
  • 3.4.1 Gastro Esophageal Reflux Disease Drug and Devices Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Gastro Esophageal Reflux Disease Drug and Devices Product Type
  • 3.4.3 Date of International Manufacturers Enter into Gastro Esophageal Reflux Disease Drug and Devices Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales by Product
• 4.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Product
• 4.3 Gastro Esophageal Reflux Disease Drug and Devices Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Gastro Esophageal Reflux Disease Drug and Devices Breakdown Data by End User

6 North America

• 6.1 North America Gastro Esophageal Reflux Disease Drug and Devices by Countries
  • 6.1.1 North America Gastro Esophageal Reflux Disease Drug and Devices Sales by Countries
  • 6.1.2 North America Gastro Esophageal Reflux Disease Drug and Devices Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Gastro Esophageal Reflux Disease Drug and Devices by Product
• 6.3 North America Gastro Esophageal Reflux Disease Drug and Devices by End User

7 Europe

• 7.1 Europe Gastro Esophageal Reflux Disease Drug and Devices by Countries
  • 7.1.1 Europe Gastro Esophageal Reflux Disease Drug and Devices Sales by Countries
  • 7.1.2 Europe Gastro Esophageal Reflux Disease Drug and Devices Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Gastro Esophageal Reflux Disease Drug and Devices by Product
• 7.3 Europe Gastro Esophageal Reflux Disease Drug and Devices by End User

8 Asia Pacific

• 8.1 Asia Pacific Gastro Esophageal Reflux Disease Drug and Devices by Countries
  • 8.1.1 Asia Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales by Countries
  • 8.1.2 Asia Pacific Gastro Esophageal Reflux Disease Drug and Devices Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Gastro Esophageal Reflux Disease Drug and Devices by Product
• 8.3 Asia Pacific Gastro Esophageal Reflux Disease Drug and Devices by End User

9 Central & South America

• 9.1 Central & South America Gastro Esophageal Reflux Disease Drug and Devices by Countries
  • 9.1.1 Central & South America Gastro Esophageal Reflux Disease Drug and Devices Sales by Countries
  • 9.1.2 Central & South America Gastro Esophageal Reflux Disease Drug and Devices Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Gastro Esophageal Reflux Disease Drug and Devices by Product
• 9.3 Central & South America Gastro Esophageal Reflux Disease Drug and Devices by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices by Countries
  • 10.1.1 Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Sales by Countries
  • 10.1.2 Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices by Product
• 10.3 Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices by End User

11 Company Profiles

• 11.1 AstraZeneca PLC
  • 11.1.1 AstraZeneca PLC Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 AstraZeneca PLC Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 AstraZeneca PLC Gastro Esophageal Reflux Disease Drug and Devices Products Offered
  • 11.1.5 AstraZeneca PLC Recent Development
• 11.2 Pfizer Inc.
  • 11.2.1 Pfizer Inc. Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Pfizer Inc. Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Pfizer Inc. Gastro Esophageal Reflux Disease Drug and Devices Products Offered
  • 11.2.5 Pfizer Inc. Recent Development
• 11.3 Johnson & Johnson
  • 11.3.1 Johnson & Johnson Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Products Offered
  • 11.3.5 Johnson & Johnson Recent Development
• 11.4 Novartis AG
  • 11.4.1 Novartis AG Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Novartis AG Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Novartis AG Gastro Esophageal Reflux Disease Drug and Devices Products Offered
  • 11.4.5 Novartis AG Recent Development
• 11.5 GlaxoSmithKline Plc
  • 11.5.1 GlaxoSmithKline Plc Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 GlaxoSmithKline Plc Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 GlaxoSmithKline Plc Gastro Esophageal Reflux Disease Drug and Devices Products Offered
  • 11.5.5 GlaxoSmithKline Plc Recent Development
• 11.6 Merck & CO., Inc.
  • 11.6.1 Merck & CO., Inc. Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Merck & CO., Inc. Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Merck & CO., Inc. Gastro Esophageal Reflux Disease Drug and Devices Products Offered
  • 11.6.5 Merck & CO., Inc. Recent Development
• 11.7 Takeda Pharmaceutical Company Limited
  • 11.7.1 Takeda Pharmaceutical Company Limited Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease Drug and Devices Products Offered
  • 11.7.5 Takeda Pharmaceutical Company Limited Recent Development
• 11.8 Boston Scientific Corporation
  • 11.8.1 Boston Scientific Corporation Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Boston Scientific Corporation Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Boston Scientific Corporation Gastro Esophageal Reflux Disease Drug and Devices Products Offered
  • 11.8.5 Boston Scientific Corporation Recent Development
• 11.9 Ironwood Pharmaceuticals, Inc.
  • 11.9.1 Ironwood Pharmaceuticals, Inc. Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Ironwood Pharmaceuticals, Inc. Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Ironwood Pharmaceuticals, Inc. Gastro Esophageal Reflux Disease Drug and Devices Products Offered
  • 11.9.5 Ironwood Pharmaceuticals, Inc. Recent Development
• 11.10 Valeant Pharmaceuticals International, Inc.
  • 11.10.1 Valeant Pharmaceuticals International, Inc. Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Valeant Pharmaceuticals International, Inc. Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Valeant Pharmaceuticals International, Inc. Gastro Esophageal Reflux Disease Drug and Devices Products Offered
  • 11.10.5 Valeant Pharmaceuticals International, Inc. Recent Development
• 11.11 Cempra Inc.
• 11.12 Medtronic Inc.
• 11.13 Medigus Ltd.
• 11.14 Teva Pharmaceuticals Industries Limited.
• 11.15 EndoGastric Solutions Inc.
• 11.16 EndoStim Inc.
• 11.17 Jeil pharmaceutical Co. Ltd.
• 11.18 Mederi Therapeutics Inc.
• 11.19 Torax Medical

12 Future Forecast

• 12.1 Gastro Esophageal Reflux Disease Drug and Devices Market Forecast by Regions
  • 12.1.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Forecast by Regions 2019-2025
• 12.2 Gastro Esophageal Reflux Disease Drug and Devices Market Forecast by Product
  • 12.2.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales Forecast by Product 2019-2025
  • 12.2.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Forecast by Product 2019-2025
• 12.3 Gastro Esophageal Reflux Disease Drug and Devices Market Forecast by End User
• 12.4 North America Gastro Esophageal Reflux Disease Drug and Devices Forecast
• 12.5 Europe Gastro Esophageal Reflux Disease Drug and Devices Forecast
• 12.6 Asia Pacific Gastro Esophageal Reflux Disease Drug and Devices Forecast
• 12.7 Central & South America Gastro Esophageal Reflux Disease Drug and Devices Forecast
• 12.8 Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Gastro Esophageal Reflux Disease Drug and Devices Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details